Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial

Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T15:54:51.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” (AI) to “Super Intelligence” (SI) terminology.
    Difference
    0.8%
    Check dated 2026-10-26T14:29:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-19T14:23:23.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-12T14:31:47.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed. This reflects an update to the record’s documentation, signaling changes were made to the record since the prior version.
    Difference
    0.1%
    Check dated 2026-09-21T22:23:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the Study Record Versions and the previous revision v3.6.5 was removed, updating the record's version history.
    Difference
    0.1%
    Check dated 2026-08-31T17:57:44.000Z thumbnail image

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.